Biomarkers, Risk Factors, and Risk: Clarifying the Controversy About Surrogate End Points and Clinical Outcomes.
Harlan M
HM
Krumholz
D015415:Biomarkers / Q000032:analysis*; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000378:metabolism / Q000628:therapy; D019468:Disease Management; D023381:Endpoint Determination / Q000379:methods*; D006801:Humans; D009017:Morbidity; D018570:Risk Assessment; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D015415:Biomarkers